These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3416742)

  • 41. Transdermal clonidine for the treatment of essential hypertension.
    McChesney JA; Ryan C; Shaw RE; Fishman-Rosen J; Murphy MC
    Compr Ther; 1987 Apr; 13(4):49-53. PubMed ID: 3568603
    [No Abstract]   [Full Text] [Related]  

  • 42. Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma dilution during transdermal clonidine antihypertensive monotherapy.
    Zawada ET; Jensen RA; Williams L; Zeigler DW; Kauker ML
    Int J Artif Organs; 1989 Mar; 12(3):200-3. PubMed ID: 2744881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
    Popli S; Daugirdas JT; Neubauer JA; Hockenberry B; Hano JE; Ing TS
    Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin pretreatment and the use of transdermal clonidine.
    Ito MK; O'Connor DT
    Am J Med; 1991 Jul; 91(1A):42S-49S. PubMed ID: 1831005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonidine withdrawal. Mechanism and frequency of rebound hypertension.
    Geyskes GG; Boer P; Dorhout Mees EJ
    Br J Clin Pharmacol; 1979 Jan; 7(1):55-62. PubMed ID: 760743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose.
    Klein C; Morton N; Kelley S; Metz S
    J Hypertens Suppl; 1985 Dec; 3(4):S81-4. PubMed ID: 3868715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of transcutaneous clonidine hydrochloride in the patient with diabetes mellitus and mild hypertension.
    Wallin JD; Krane NK; Bergman S; Morgan M
    J Clin Hypertens; 1985 Dec; 1(4):315-21. PubMed ID: 3836300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats.
    Ishii R; Furuta M; Hashimoto M; Tagawa T; Naruse T; Hata T
    Arzneimittelforschung; 1998 Aug; 48(8):811-7. PubMed ID: 9748708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides.
    Polster AM; Warner MR; Camisa C
    Cutis; 1999 Mar; 63(3):154-5. PubMed ID: 10190065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal clonidine as an adjunct to enalapril: an evaluation of efficacy and patient compliance.
    Weidler D; Wallin JD; Cook E; Dillard D; Lewin A
    J Clin Pharmacol; 1992 May; 32(5):444-9. PubMed ID: 1587962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transdermal clonidine application: long-term results in essential hypertension.
    Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
    Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonidine through the skin in the treatment of essential hypertension: is it practical?
    Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
    J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of a transdermal formulation of clonidine in mild to moderate hypertension and its effects on the arterial and venous vasculature of the forearm.
    Achimastos A; Girerd X; Simon AC; Pithois-Merli I; Levenson J
    Eur J Clin Pharmacol; 1987; 33(2):111-4. PubMed ID: 3691604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodynamic changes at rest and during exercise in long-term clonidine therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1974; 195(1-2):111-5. PubMed ID: 4817078
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects.
    Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children].
    Kang H; Zhang YF; Jiao FY; Guo XY; Gao XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):537-9. PubMed ID: 19650984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamic and metabolic effects of transdermal clonidine in patients with hypertension and non-insulin-dependent diabetes mellitus.
    Giugliano D; Acampora R; Marfella R; La Marca C; Marfella M; Nappo F; D'Onofrio F
    Am J Hypertens; 1998 Feb; 11(2):184-9. PubMed ID: 9524046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine.
    Zawaideh MA; Duncan B; Joseph MW; Dixit MP
    Pediatr Nephrol; 2001 Jan; 16(1):85-6. PubMed ID: 11198612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.